Clinical Component Director: Paul Monga, MD
Commercialization: Scott Morley, MBA, Coulter Program Director
Diagnostics: Aatur Singhi, MD, PhD
Biostatistician and Bioinformatic Support: Silvia Liu, PhD
The Clinical Component of the PLRC provides clinical and basic expertise, resources to facilitate the translation of basic research into novel diagnostic and therapeutic tools all the way from discovery to commercialization. To request services, please download the pdf form (available here), complete it, and send it to Ann Vinski (vinskiam@upmc.edu).
- Consultation for suitability of a project for commercialization
- Helping with innovation disclosure and IP filing
- Assistance with licensing an innovation
- Assistance and guidance on start-ups
- Pathology services for interpreting patient samples
- Histopathological assessment on preclinical models
- Statistical support, power analysis
- Data mining
- Clinical consultation on a basic research project, discussion on unmet clinical need, relevance of a preclinical model in representing human disease (committee listed below)
- Basic research consultation for a research project, input on best and acceptable preclinical models, fundamental concepts in liver health and disease (committee listed below)
Clinical Consultation Committee
Area |
Expert |
Primary Department/Division |
---|---|---|
Non-alcoholic liver disease |
Jaideep Behari, MD, PhD |
Medicine/GI, Hepatology and Nutrition |
Alcoholic liver disease |
Ramon Bataller, MD, PhD |
Medicine/GI, Hepatology and Nutrition |
Endocrinology |
Erin Kershaw, MD |
Medicine/Endocrinology and Metabolism |
Viral hepatitis & Cholestasis |
Naudia Jonassaint, MD |
Medicine/GI, Hepatology and Nutrition |
Cirrhosis |
Andres Rojo-Duarte, MD |
Medicine/GI, Hepatology and Nutrition |
Genetic and rare diseases |
Jerry Vockley, MD, PhD |
Genetics/Pediatrics, CHP |
Portal hypertension |
Vikrant Rachakonda, MD |
Medicine/GI, Hepatology and Nutrition |
Transplant hepatology |
Swaytha Ganesh, MD |
Medicine/GI, Hepatology and Nutrition |
Pediatric hepatology-I |
Robert Squires, MD |
Pediatrics/GI and Hepatology |
Pediatric hepatology-II |
Patrick McKiernan, MD |
Pediatrics/GI and Hepatology |
Liver Transplantation |
Chris Hughes, MD |
Department of Surgery/Abdominal Transplantation |
Liver cancer |
David Geller, MD |
Department of Surgery/Hepatobiliary & Pancreatic |
Basic Research Consultation Committee
Area |
Expert |
Primary Department/Division |
---|---|---|
Liver development, zonation, tumors |
Paul Monga, MD |
Pathology and Medicine |
Liver regeneration |
George Michalopoulos, MD, PhD |
Pathology |
Liver metabolism |
Wen Xie, MD, PhD |
Pharmacy |
Stem cells / cell therapy / gene therapy / gene editing |
Alex Soto-Gutierrez, MD, PhD and Mo Ebrahimkhani, MD |
Pathology |
Organ-on-chip and Drug Discovery |
Lans Taylor, PhD |
Drug Discovery Institute |
Liver fibrosis, ALD |
Gavin Arteel, PhD |
Medicine/GI, Hepatology and Nutrition |
NAFLD |
Michael Jurczak, PhD |
Medicine/Endocrinology and Metabolism |
Liver immunology |
Angus Thompson, PhD, DSc |
Surgery and Immunology |
Pediatric liver diseases |
Drew Feranchak, MD |
Pediatrics/GI and Hepatology |
Cholangiopathies |
Kari Nejak-Bowen, MBA, PhD |
Pathology |
Zebrafish models |
Donghin Shin, PhD |
Developmental biology |